Abstract
726P Efficacy and safety of pembrolizumab plus olaparib combination therapy in recurrent cervical cancer progressed on platinum-based chemotherapy: Results from the phase II trial of GOTIC-025
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have